National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical utilization of cardiac biomarker testing in heart failure

被引：49
作者：
Tang, W. H. Wilson [6 ]
Francis, Gary S. [6 ]
Morrow, David A. [5 ]
Newby, L. Kristin [4 ]
Cannon, Christopher P. [5 ]
Jesse, Robert L. [3 ]
Storrow, Alan B. [2 ]
Christenson, Robert H. [1 ]
机构：
[1] Univ Maryland, Sch Med, Baltimore, MD 21201 USA
[2] Vanderbilt Univ, Nashville, TN USA
[3] Virginia Commonwealth Univ, Med Coll Virginia, Richmond, VA 23298 USA
[4] Duke Univ, Med Ctr, Durham, NC 27706 USA
[5] Harvard Univ, Brigham & Womens Hosp, Boston, MA 02115 USA
[6] Cleveland Clin Fdn, Cleveland, OH 44195 USA
来源：
CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 4-5期
关键词：
D O I：
10.1016/j.clinbiochem.2007.07.002
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：210 / 221
页数：12
相关论文
共 148 条
[91]  
NG LL, 2003, CLIN SCI LOND
[92]   Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population [J].
Nielsen, OW ;
McDonagh, TA ;
Robb, SD ;
Dargie, HJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (01) :113-120
[93]   Pre-discharge, but not admission, levels of NT-proBNP predict adverse prognosis following acute LVF [J].
O'Brien, RJ ;
Squire, IB ;
Demme, B ;
Davies, JE ;
Ng, LL .
EUROPEAN JOURNAL OF HEART FAILURE, 2003, 5 (04) :499-506
[94]   Myotrophin in human heart failure [J].
O'Brien, RJ ;
Loke, I ;
Davies, JE ;
Squire, IB ;
Ng, LL .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :719-725
[95]   The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients [J].
O'Hanlon, Rory ;
O'Shea, Paula ;
Ledwidge, Mark ;
O'Loughlin, Christina ;
Lange, Sophie ;
Conlon, Carmel ;
Phelan, Dermot ;
Cunningham, Sean ;
Mcdonald, Ken .
JOURNAL OF CARDIAC FAILURE, 2007, 13 (01) :50-55
[96]   B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure [J].
O'Neill, JO ;
Bott-Silverman, CE ;
McRae, AT ;
Troughton, RW ;
Ng, K ;
Starling, RC ;
Young, JB .
AMERICAN HEART JOURNAL, 2005, 149 (02) :363-369
[97]   N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes [J].
Omland, T ;
Persson, A ;
Ng, L ;
O'Brien, R ;
Karlsson, T ;
Herlitz, J ;
Hartford, M ;
Caidahl, K .
CIRCULATION, 2002, 106 (23) :2913-2918
[98]   Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? [J].
Packer, M .
CIRCULATION, 2003, 108 (24) :2950-2953
[99]   Ongoing myocardial injury in stable severe heart failure -: Value of cardiac troponin T monitoring for high-risk patient identification [J].
Perna, ER ;
Macin, SM ;
Canella, JPC ;
Augier, N ;
Stival, JLR ;
Cialzeta, JR ;
Pitzus, AE ;
Garcia, EH ;
Obregón, R ;
Brizuela, M ;
Barbagelata, A .
CIRCULATION, 2004, 110 (16) :2376-2382
[100]   Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure [J].
Perna, ER ;
Macín, SM ;
Canella, JPC ;
Alvarenga, PM ;
Ríos, NG ;
Pantich, R ;
Augier, N ;
Farías, EF ;
Jantus, E ;
Brizuela, M ;
Medina, F .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (02) :253-261
567891011121314